Chemical Bank raised its position in Agilent Technologies Inc (NYSE:A) by 17.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 10,855 shares of the medical research company’s stock after acquiring an additional 1,607 shares during the period. Chemical Bank’s holdings in Agilent Technologies were worth $872,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in A. Parallel Advisors LLC increased its position in shares of Agilent Technologies by 3.9% during the 4th quarter. Parallel Advisors LLC now owns 4,002 shares of the medical research company’s stock worth $269,000 after purchasing an additional 149 shares during the last quarter. Fruth Investment Management increased its position in shares of Agilent Technologies by 0.3% during the 4th quarter. Fruth Investment Management now owns 45,351 shares of the medical research company’s stock worth $3,059,000 after purchasing an additional 150 shares during the last quarter. BOKF NA increased its position in shares of Agilent Technologies by 1.4% during the 4th quarter. BOKF NA now owns 11,229 shares of the medical research company’s stock worth $757,000 after purchasing an additional 158 shares during the last quarter. Sumitomo Life Insurance Co. increased its position in shares of Agilent Technologies by 1.3% during the 4th quarter. Sumitomo Life Insurance Co. now owns 13,394 shares of the medical research company’s stock worth $904,000 after purchasing an additional 178 shares during the last quarter. Finally, Mission Wealth Management LP increased its position in shares of Agilent Technologies by 2.1% during the 4th quarter. Mission Wealth Management LP now owns 8,629 shares of the medical research company’s stock worth $582,000 after purchasing an additional 179 shares during the last quarter.

A opened at $76.01 on Thursday. The firm has a market capitalization of $23.45 billion, a P/E ratio of 27.24, a PEG ratio of 2.05 and a beta of 1.33. Agilent Technologies Inc has a 1 year low of $60.42 and a 1 year high of $82.27. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.27 billion. Agilent Technologies had a net margin of 22.86% and a return on equity of 19.90%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.65 earnings per share. On average, research analysts expect that Agilent Technologies Inc will post 3.06 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were given a dividend of $0.164 per share. The ex-dividend date of this dividend was Monday, April 1st. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.86%. Agilent Technologies’s payout ratio is 23.66%.

In other news, VP Mark Doak sold 16,421 shares of the company’s stock in a transaction on Friday, February 22nd. The stock was sold at an average price of $77.95, for a total transaction of $1,280,016.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Michael Tang sold 6,728 shares of the company’s stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total value of $541,604.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,329 shares of company stock valued at $4,535,225.

A number of research analysts recently weighed in on the company. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $79.00 target price on the stock in a report on Monday, January 21st. UBS Group assumed coverage on Agilent Technologies in a report on Friday, March 15th. They set a “buy” rating and a $92.00 target price on the stock. Needham & Company LLC reissued a “buy” rating and set a $88.00 target price (up from $77.00) on shares of Agilent Technologies in a report on Monday, February 25th. Janney Montgomery Scott reissued a “buy” rating and set a $90.00 target price (up from $80.00) on shares of Agilent Technologies in a report on Thursday, February 21st. Finally, Bank of America reissued a “buy” rating and set a $87.00 target price (up from $78.00) on shares of Agilent Technologies in a report on Thursday, February 21st. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $86.58.

ILLEGAL ACTIVITY NOTICE: “Chemical Bank Grows Holdings in Agilent Technologies Inc (A)” was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://theolympiareport.com/2019/05/16/chemical-bank-grows-holdings-in-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Purposes and Functions of the Federal Reserve

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.